Skip to main content
Premium Trial:

Request an Annual Quote

Akonni Gets $500K SBIR Grant for Array Consumables

NEW YORK (GenomeWeb News) – Akonni Biosystems today said that it has received a $498,780 Phase 2 SBIR award from the National Science Foundation to further develop its Lab-on-a-Film microarray consumable technology.

The award is the second round of funding from NSF and specifically will support development of a consumable that can run on ultra-low-cost film using a highly automated, reel-to-reel production process, the Frederick, Md.-based firm said. It received a $150,000 award from NSF in December 2010 for the Lab-on-a-Film technology.

Akonni plans to integrate the Lab-on-a-Film consumable into its "hands-free, end-to-end" genetic testing system, which is being developed for use in moderate-complexity lab settings.

"Reel-to-reel assembly is a method of high volume manufacturing used predominantly for the assembly of lateral flow strips and flexible film electronics," Christopher Cooney, director of engineering at Akonni, said in a statement. "The benefit of this manufacturing approach is that Lab-on-a-Film microarray production and assembly can be automated at very high speeds, resulting in ten- to one hundred-fold savings in consumable costs."

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.